BioTrinity 2024

We are happy to announce we will be speaking at OBN's BioTrinity 2024 conference!

The Cell and Gene Therapy Catapult will be speaking on the Business Track at this two-day event.

Speaking from the Cell and Gene Therapy Catapult

Talk: 23rd April, 13:30 - 14:30: "Panel: A Discussion on the latest regulatory updates impacting biotech and medtech SMEs. How to ensure compliance and overcome challenges?"

Speaker: Chris Carr, Head of Regulatory Affairs